Compound Detail
CHEMBL5856367
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nc(N2CCO[C@H](C(F)(F)F)C2)c2[nH]c(N)c(S(=O)(=O)c3ccc(F)cc3F)c2n1
Basic Information
| ChEMBL ID | CHEMBL5856367 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IXXZSRAIVCLCIK-LBPRGKRZSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
477.4
MW (Da)
2.73
ALogP
7
HBA
2
HBD
114.2
PSA (Ų)
0.44
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Free fatty acid receptor 2 CHEMBL5493 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Free fatty acid receptor 2 | EC50 | = | 2.0 | nM | 8.7 | Ca-Flux Functional Assay: GPR43 agonist/PAM activity was determined by measuring... | - |
Data from ChEMBL 36 via Core Engine